Mednet

The AI is only as good as the knowledge behind it. Mednet AI is a clinical assistant built on a foundation ten years in the making — 40,000+ physicians and 3,400 academic experts. ➝ themednet.org/?utm_source=x&… #MednetAI #AI #MedTwitter

"Game-changer compared to traditional LLMs." — Panicker Renni Robinson, MD, Cardiology Fellow That's what Mednet AI was built for. Evidence + real expert opinion, combined. Free for all US physicians. ➝ themednet.org/?utm_source=x&… #MednetAI #AI #MedTwitter

@fumikochino @fumikochino ✅✅✅ from an AI hater is more than we could have hoped for! Thank you for sharing.

I was impressed with @themednet's new AI tool. Preference for sources from high quality journals including guidelines, with additional tailored recs sourced from the extant expert content already present in Mednet. ✅✅✅ I'm a bit of an AI hater but thought this was useful.

@DrSpratticus @DrSpratticus play as much as you like! We'd love your feedback as we continue to evolve

AI is everywhere. Mednet has added some nice AI features to simulatenously answer questions using only guidelines and scientific information, while also it appears to show relevant mednet posts/discussions on the side. Will be fascinating as this evolves how these can continue to integrate. Nice feature! Will need to play :) #radonc

Most clinical assistants answer: what does the research say? Mednet AI answers: what do experienced physicians actually do? There's a difference. ➝ themednet.org/?utm_source=x&… #MednetAI #AI #MedTwitter

We've got big news!! Mednet AI is now live — a clinical assistant informed by 10 years of real-world conversations from 40,000+ physicians, combined with the best of medical research. Free for all Mednet physicians. Ask us anything. ➝ tinyurl.com/vve66cbv #MednetAI #AI #MedTwitter

New on IDSA - @PaulSaxMD interviews Patrick Passarelli (Dartmouth-Hitchcock; ID editor @themednet) on getting expert guidance beyond AI + what makes a great clinical question. idsociety.org/multimedia/pod… #IDTwitter #MedEd #InfectiousDiseases

@ASTRO_org Link to relevant Q&A: In mCRPC patients who had an initial response to Pluvicto but progress within 12 months, where do you position PSMA radioligand retreatment relative to other next-line systemic options in your sequencing strategy? themednet.org/v2/programs/19…

@ASTRO_org Link to relevant Q&A: What criteria are you using for retreatment with Pluvicto (Lu-177) in those who maintain a good performance status and appropriate lab work? themednet.org/v2/programs/19…"

The American Society for Radiation Oncology (@ASTRO_org) #MRPTS26 plenary session on Radiopharmaceutical Retreatment (Plenary II) just concluded. Dr. Ana Kiess is answering questions now on theMednet. Head to the Q&A → themednet.org/v2/programs/19…

@ASTRO_org @NeilTaunkMD Link to relevant Q&A: Does the possibility of future Lu-177–PSMA therapy change your current threshold to offer earlier metastasis-directed RT in oligometastatic prostate cancer? themednet.org/v2/programs/19… #MRPTS26

@ASTRO_org @NeilTaunkMD Link to relevant Q&A: Can you give Pluvicto with concurrent palliative EBRT? themednet.org/v2/programs/19… #MRPTS26

The American Society for Radiation Oncology (@ASTRO_org) #MRPTS26 plenary session on Clinical Outcomes among Patients Treated with Lu-PSMA-617 and EBRT for Oligometastatic Prostate Cancer just concluded. Dr. Neil K Taunk (@NeilTaunkMD) is answering questions now on theMednet.

Links to relevant Q&A: Do you modify dosing and monitoring of Lu-177–PSMA therapy for patients with prior large-field RT involving substantial active marrow compared with patients who only had focal bone SBRT? - themednet.org/v2/programs/19… When selecting mCRPC patients for Pluvicto, which baseline variables do you find most useful or predictive of potential hematologic toxicity? - themednet.org/v2/programs/19…

The American Society for Radiation Oncology (@ASTRO_org) #MRPTS26 plenary session on Hematologic Toxicity Outcomes of Lu-PSMA-617 in Patients Previously Treated with EBRT for Oligometastatic Disease just concluded. Drs. Neil K Taunk (@NeilTaunkMD) & Krishnan R Patel (@krishnan_patel) are answering questions now on theMednet. Head to the Q&A → themednet.org/v2/programs/19…